Program Schedule

2018 Schedule 

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Cardiovascular Nursing Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management.

Audience at Cardiovascular Nursing Symposium

Wednesday, April 4           Pharmacology Preconference

Pharmacology Preconference may be attended as a stand-alone event.

    

                            
11:00 AM    Lunch 
11:15 AM    Treating High-Risk Patients with Dyslipidemia: Evidence and Challenges
Kathleen Byrne, MSN, CRNP, CCRN
This program is open to all attendees, not just those registered for the Preconference
12:30 PM        Welcome and Course Overview
12:45 PM   Medication Management of Excess Weight and Co-morbid Conditions
Melissa Davis, DNP, ANP-BC, CNS, CBN, CNOR, RNFA
2:00 PM    Movement Activity Break 
2:15 PM
Anti-Hyperglycemic Therapies: Improving CVD Outcomes
Cindy Lamendola, MSN, NP, FAHA, FPCNA
3:30 PM
Beverage Break
3:45 PM   Medications to Manage Rate, Rhythm and Symptoms Associated with Atrial Fibrillation and Flutter
T. Jennifer Walker, ANP-BC
5:00 PM    Case Study Panel Discussion
5:30 PM    Break 
5:45 PM   Non-CE Dinner Event
A Closer Look at Unmet Needs Related to Statin Treatment
Product Theater by Kowa Pharmaceuticals America, Inc.

Thursday, April 5       Annual Symposium General Sessions

7:30 AM    Breakfast 
7:40 AM    Welcome and Announcements
8:00 AM   Cardiovascular Risk Reduction and LDL-C: Evolving Perspectives
Margo Minissian, PhDc, ANCP-BC, CLS-BC, CNS, AACC, FAHA
Robert Giuliano, MD, MSc
9:00 AM   Stretch Break 
9:30 AM   Opening Keynote: Big Data and the Future of CVD Prevention and Treatment
Eric D. Peterson, MD, MPH, FAHA, FACC
10:30 AM   Movement Activity and Beverage Break 
10:45 AM   Genetic Counseling and Inherited CVD: A Family Affair
Colleen Caleshu, ScM, CGC
11:30 AM
Pediatric Prevention Guidelines: Its Never Too Early (Or Too Late) to Focus on Heart Health
Laura Hayman, PhD, RN, FPCNA, FAAN
12:30 PM   Non-CE Lunch Event
Cardiovascular Disease Burden in the U.S. and Clinical Evaluation of Vascepa® (icosapent ethyl)
Product Theater by Amarin Pharma, Inc.
1:00 PM to 
2:45 PM
  Exhibit Hall Open
2:30 PM   Skill Building Sessions (pick one)

Don't Sleep On It! Integrating Sleep Assessments and Treatments in Your CVD Practice
Lisa L.M. Maher, DNP, ARNP, FNP-B

CVD Imaging: A Primer in Test Selection, Interpretation and Application
M. Dominique Ashen, CRNP, PhD

Moderated Poster Session
4:45 PM   It's Easy Being Green: Lifestyle Medicine and Plant-Based Diets
Kim Allen Williams, MD, Sr., MACC, FAHA, MASNC, FESC
5:45 PM   Opening Reception in the Exhibit Hall with Poster Presentations
Sponsored by the Journal of Cardiovascular Nursing
7:30 PM   Non-CE Dinner Event
Clinical Data and Real-World Evidence to Support NVAF & DVT/PE Treatment Decision-Making
Product Theater by Janssen Pharmaceuticals, Inc.

Friday, April 6

7:30 AM    Breakfast 
7:45 AM    Welcome and Announcements 
8:00 AM            Undiagnosed Non-Valvular Atrial Fibrillation and Stroke Risk: A Call to Action
Kathy Berra, MSN, ANP, FAHA, FPCNA, FAAN
Jonathan Chrispin, MD
Mellanie True-Hills, CSP
8:45 AM
  Exhibit Hall Open
9:45 AM   The Weight of the World: Reducing Stroke and CVD Disparities
George Mensah, MD, FAHA
10:45 AM    Poster Winners Announced
11:00 AM - 12:00 PM   Winning Oral Abstract Presentations
  • Identification of Familial Hypercholesterolemia in a Cardiology Practice
  • Patient-Reported Outcomes in Individuals with Atrial Fibrillation Differ by Sex, Age and Education
  • Non-Invasive Screening Tools and Predictors of Prediabetes: Review and Synthesis of Literature
  • Cardiovascular Risk Assessment Among Adults with Osteoarthritis Taking Medication for Metabolic Syndrome: A Preliminary Finding
11:45 AM    Last Chance: Exhibit Hall Open and Raffle Drawing
12:45 PM   Non-CE Lunch Event
Repatha® (evolocumab): Putting it into Practice
Product Theater by Amgen, Inc.
1:45 PM   New Hypertension Guidelines: Matching Risks and Treatments
Cheryl R. Dennison Himmelfarb, RN, ANP, PhD, FAHA, FPCNA, FAAN
2:30 PM   Managing CVD Risks in Older Adults: Lessons from a Geriatric Cardiology Practice
Daniel E. Forman, MD
3:15 PM   Afternoon Break
3:30 PM    Breakout Sessions (pick one)
    Palliative Care: Ensuring Quality of Life Across the Spectrum of CVD
Patricia Davidson, PhD, MED, RN, FAAN

Managing Atrial Fibrillation: Devices and Interventions
Mary Eng Huntsinger, MSN, CNS, ACNP-BC

Cardio-Renal Syndrome: Managing Risk and Treating Disease
Marie Galvao, MSN, ANP-BC, CHFN
5:00 PM    Non-CE Dinner Event
Access to Innovative Medicines Round Table and Town Hall
Kim Newlin, MSN, ANP, FPCNA
Susan Halli-Demeter, DNP, RN, FNP-BC, CLS
Mellanie True-Hills, CSP
Cat Davis Ahmed, MBA
Seth Baum, MD, FAAC, FACPM, FAHA, FNLA, FASPC

Saturday, April 7

7:00 AM              Breakfast 
7:30 AM   Non-CE Breakfast Session
Optimizing Treatment to Improve Outcomes - Implementing the New Guidelines for Managing Heart Failure with Reduced Ejection Fraction
Sponsored by Novartis Pharmaceuticals, Inc.
8:40 AM   PCNA Member Celebration and Awards Ceremony
9:00 AM   CVD Risk Stratification and a Life-Course Perspective on Risk Communication
Roger S. Blumenthal, MD, FACC, FAHA, FNLA
9:45 AM Movement Activity and Beverage Break

10:00 AM

Cardiac Rehab in 2018: Incorporating New Populations and Approaches
Barry Franklin, PhD, FACSM, FAACVPR, FAHA
10:45 AM   Closing Keynote: Caring for Ourselves So We Can Care for Others
Cynda Rushton, PhD, RN, FAAN
11:45 AM    Closing Remarks and Prize Drawings

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.